First
Quarter Sales to HUT Group Doubled Over 2014.
Partnership
Expansion on Track to Reach Over $500,000 Sales in Europe.
Fort
Lee, N.J. March 27, 2015 Herborium® Group, Inc. (OTC Pink: HBRM),
www.Herborium.com, a Botanical
Therapeutics®
Company and the provider of unique all botanical medicines (Botanical
Therapeutics®) announced today that its sales to HUT Group, LLC. ,
the UK’s leading multi-website online retailer of Health and Beauty
products has doubled over the same period of 2014.
As
agreed to in the revised Agreement in December 2014 HUT has
successfully increased its marketing and sales of AcnEase®,
Herborium’s unique acne treatment, on its multiple highly ranked e-
commerce platforms, and therefore kept the sale projection on track
for reaching $500,000 sales in Europe within 18-24 months.
The
HUT Group is one of Europe's fastest growing online lifestyle and
health & and beauty destinations. It is currently the UK’s
leading multi-website online retailer with rapidly growing global
operations including a significant growth in Asia. Hut supports more
than 140 million global website visitors, 5 million customers and 8
million orders dispatched worldwide across such on line stores as
www.myprotein.com, www.LookFantastic.com, www.beautyexpert.co.uk,
mankind.co.uk, www.coggles.com and others.
“We
are very excited about the present growth in sales of AcnEase® by
using HUT’s unique “end
to end” technology
platform. With potential for a million page views daily our Botanical
Therapeutics® will reach millions of customers in Europe and Asia.
We are expecting HUT goal for $500,000 in sales of AcnEase® to be
just a beginning of Herborium’s new growth opportunities in Europe
that are also strongly supported by the continuous growth of our
French market sales. France is the 4th
largest
world market for beauty and skincare related products. ” commented
Dr. Agnes P. Olszewski, CEO and Chairwoman of Herborium.
About
Herborium Group, Inc.
Herborium
Group, Inc., a botanical therapeutics® company that develops,
license and markets proprietary, botanical based medicinal products
to consumers and healthcare professionals. The Company business model
focuses on emerging market opportunities spearheaded by the growth of
a new market sector located between high-cost, high-risk, ethical
pharmaceuticals and commoditized classic nutraceuticals
(supplements). The Company uses clinical validation and a proactive
regulatory strategy based on the FDA Guidance for Industry: Botanical
Drug Products (FDA Guidance 2004) to
establish and maintain a differential advantage. Herborium has
secured a pipeline of botanical ingredients based products in the
areas of dermatological needs, wellness and energy, prostate health,
women’s health and selected sexual disorders resulting from
cardiovascular disease, use of anti-depressants, diabetes, surgical
procedures, and other problems. Herborium Group sells its products in
the United States, the United Kingdom, and continental Europe through
a network of distributors, specialty retailers, and e-commerce. For
more information, please visit www.herborium.com, www.acnease.com and
www.acnease.fr
Safe
Harbor Statement: This release contains forward-looking statements
with respect to the results of operations and business of Herborium
Group, Inc., which involves risks and uncertainties. The Company's
actual future results could materially differ from those discussed.
The Company intends that such statements about the Company's future
expectations, including future revenues and earnings, and all other
forward looking statements be subject to the "Safe Harbors"
provision of the Private Securities Litigation Reform Act of 1995.
Contact
Information:
Herborium
Group, Inc.
Email:
InvestorsRelations@Herborium.com
No comments:
Post a Comment